Morana Jovan-Embiricos - Director at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Morana Jovan-Embiricos since 11 Feb 2025

Holdings reported by Morana Jovan-Embiricos for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,674,766 $13,211,417 $0.7923 06 Jun 2024 Shares held by ElevateBio LLC
Common Stock 4,193,874 $3,322,806 $0.7923 06 Jun 2024 F2 Capital I 2020 LLC
Common Stock 2,059,884 $1,632,046 $0.7923 06 Jun 2024 F2 MG Ltd.
Common Stock 2,038,583 $1,615,169 $0.7923 06 Jun 2024 Shares held by F2 MC, LLC
Common Stock 867,678 $687,461 $0.7923 06 Jun 2024 F2 Bioscience AV 2022 LLC
Common Stock 668,072 $529,313 $0.7923 06 Jun 2024 Shares held by F2 TPO Investments, LLC
Common Stock 100,197 $79,386 $0.7923 06 Jun 2024 Direct
Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct Common Stock

Transactions reported by Morana Jovan-Embiricos for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.